China's CanSino to begin Phase III clinical trials
Note: This section contains information in English only.
Mon, 10 Aug 2020 03:02:10 GMT
Source: Dukascopy Bank SA
The Chinese vaccine maker CanSino Biologics will soon begin the Phase III clinical trials of the COVID-19 vaccine in Saudi Arabia, a spokesperson from the Saudi Health Ministry announced on Sunday.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.